Abbott completes acquisition of Visiogen - - ModernMedicine
Abbott completes acquisition of Visiogen

Source: Ophthalmology Times E-News

Abbott Park, IL—Abbott Laboratories has completed its acquisition of privately held eye-care company Visiogen, adding to its vision-care business an accommodating IOL technology (Synchrony) designed to address presbyopia in patients with cataracts.

The $400 million cash purchase boosts Abbott’s presence in the vision-care segment, which it entered in February with the acquisition of Advanced Medical Optics, according to a prepared statement from the company.

“Visiogen immediately provides Abbott Medical Optics [AMO] with a talented team of dedicated professionals and an entry point into the accommodating IOL market,” said Jim Mazzo, senior vice president, AMO.

The proprietary accommodating IOL received CE mark designation and has been available commercially in Europe since January. It is under review by the FDA.
post a comment
Your email address will NOT be published.
appears with your comment
read our privacy policy
Note: does not support HTML
All comments submitted are subject to review and may be delayed before posting. We reserve the right not to post comments. Comments from patients or members of patients' families seeking medical advice will not be posted.
eSamples check closet
eSamples check closet
Practice ToolsPractice Tools
Coding Counselor
Coding Counselor

Simple and accurate ICD-9 code search. Start Here

Patient Education
Patient Education

Print customized patient education handouts. Start Here

Dermatology Diagnosis
Dermatology Diagnosis

Identify skin diseases by age, gender, location. Start Here

AHRQ Clinical Guidelines
AHRQ Clinical Guidelines

Objective findings on medical interventions. Start Here



Source: Ophthalmology Times E-News,
Click here